1 – 10 of 74
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Impact of TCF7L2 rs7903146 on clinical presentation and risk of complications in patients with type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
(
- Contribution to journal › Article
-
Mark
The effect of the endothelin receptor antagonist atrasentan on insulin resistance in phenotypic clusters of patients with type 2 diabetes and chronic kidney disease
(
- Contribution to journal › Article
- 2024
-
Mark
Vulvovaginal candidiasis and type 2 diabetes : A nationwide retrospective cohort study
(
- Contribution to journal › Article
-
Mark
Low-grade inflammation in persons with recently diagnosed type 2 diabetes : The role of abdominal adiposity and putative mediators
(
- Contribution to journal › Article
-
Mark
Beneficial effect of oral semaglutide for type 2 diabetes mellitus in patients with metabolic dysfunction-associated steatotic liver disease : A prospective, multicentre, observational study
(
- Contribution to journal › Article
-
Mark
Lipids and apolipoproteins and the risk of vascular disease and mortality outcomes in women and men with type 2 diabetes in the ADVANCE study
(
- Contribution to journal › Article
- 2023
-
Mark
Model-based predictions on health benefits and budget impact of implementing empagliflozin in people with type 2 diabetes and established cardiovascular disease
(
- Contribution to journal › Article
-
Mark
Burden of established cardiovascular disease in people with type 2 diabetes and matched controls : Hospital-based care, days absent from work, costs and mortality
(
- Contribution to journal › Article
- 2021
-
Mark
Interaction of diabetes genetic risk and successful lifestyle modification in the Diabetes Prevention Programme
(
- Contribution to journal › Article